00648 京玖康療
按盘价 
0.250 -0.005 (-1.961%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | 13.463% | 589.339% | 31.001% | -87.876% | -113.225% |
| 股东资金回报率 (%) | 46.547% | N/A | N/A | N/A | N/A |
| 资本运用回报率 (%) | 25.206% | 10851.912% | N/A | N/A | N/A |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 33.107% | 33.672% | 41.147% | 40.684% | 46.498% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 16.415% | 603.377% | 54.801% | 2.722% | -427.016% |
| 税前边际利润率 (%) | 13.845% | 600.220% | 27.988% | -49.258% | -1454.797% |
| 纯利率 (%) | 10.184% | 597.224% | 24.369% | -56.938% | -1546.498% |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 2.288 X | 0.964 X | 0.093 X | 0.051 X | 0.045 X |
| 速动比率 (X) | 2.029 X | 0.872 X | 0.086 X | 0.045 X | 0.045 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 43.582% | 95.507% | 677.570% | 1495.921% | 1799.885% |
| 总债项 / 总资产比率 (%) | 26.041% | 62.244% | 518.991% | 1122.252% | 1428.370% |
| 净债项 / 总资产比率 (%) | 1.282% | 46.196% | 504.603% | 1109.688% | 1409.166% |
| 总债项 / 股东资金比率 (%) | 46.158% | 1385.464% | N/A | N/A | N/A |
| 长期债项 / 股东资金比率 (%) | 0.609% | 22.435% | N/A | N/A | N/A |
| 净债项 / 股东资金比率 (%) | 2.273% | 1028.257% | N/A | N/A | N/A |
| 净现金 / (债项) ($) | (62.30万) | (2.53千万) | (2.83亿) | (2.73亿) | (2.69亿) |
| 每股净现金 / (债项) ($) | 0.000 | (0.077) | (0.868) | (0.839) | (0.826) |
| 总债项 / 资本运用比率 (%) | 45.878% | 1131.593% | N/A | N/A | N/A |
| 利息盈利率 (X) | 7.763 X | 249.262 X | 2.110 X | N/A | N/A |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 40.854日 | 38.327日 | 28.992日 | 35.902日 | N/A |
| 应收贸易帐周转率日数 (日) | 85.103日 | 79.651日 | 28.953日 | 14.604日 | 195.712日 |
| 应付贸易帐周转率日数 (日) | 34.843日 | 67.343日 | N/A | N/A | N/A |
| 备注： | 实时报价更新时间为02/04/2026 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | HKD 6,950 |
| 增长率 | -97.870% |
| 每股盈利/(亏损) | HKD 0.012 |
| 每股账面资产净值 ($) | HKD 0.013 |